Laurion Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Hold |
867,046
| – | – | 0.02% | 91 |
|
|
2025
Q1 | $954K | Hold |
867,046
| – | – | 0.02% | 90 |
|
|
2024
Q4 | $1.49M | Hold |
867,046
| – | – | 0.03% | 82 |
|
|
2024
Q3 | $2.15M | Sell |
867,046
-311,292
| -26% | -$772K | 0.03% | 78 |
|
|
2024
Q2 | $2.85M | Sell |
1,178,338
-716,685
| -38% | -$1.73M | 0.03% | 95 |
|
|
2024
Q1 | $7.67M | Hold |
1,895,023
| – | – | 0.07% | 104 |
|
|
2023
Q4 | $7.28M | Hold |
1,895,023
| – | – | 0.06% | 64 |
|
|
2023
Q3 | $7.86M | Buy |
1,895,023
+688,475
| +57% | +$2.86M | 0.05% | 70 |
|
|
2023
Q2 | $5.8M | Hold |
1,206,548
| – | – | 0.03% | 60 |
|
|
2023
Q1 | $4.9M | Hold |
1,206,548
| – | – | 0.03% | 73 |
|
|
2022
Q4 | $6.52M | Hold |
1,206,548
| – | – | 0.03% | 73 |
|
|
2022
Q3 | $12.1M | Hold |
1,206,548
| – | – | 0.07% | 57 |
|
|
2022
Q2 | $5.67M | Buy |
1,206,548
+549,700
| +84% | +$2.58M | 0.09% | 55 |
|
|
2022
Q1 | $2.57M | Hold |
656,848
| – | – | 0.03% | 97 |
|
|
2021
Q4 | $4.44M | Hold |
656,848
| – | – | 0.04% | 90 |
|
|
2021
Q3 | $9.76M | Buy |
+656,848
| New | +$9.76M | 0.04% | 105 |
|